MHR
DXCM icon

Matthew Hamilton Rosenberg’s DexCom DXCM Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22
Closed -$1.48K – 817
2024
Q3 		$1.48K Hold
22
– – ﹤0.01% 759
2024
Q2 		$2.47K Hold
22
– – ﹤0.01% 706
2024
Q1 		$3.04K Hold
22
– – ﹤0.01% 732
2023
Q4 		$2.73K Hold
22
– – ﹤0.01% 748
2023
Q3 		$2.05K Hold
22
– – ﹤0.01% 750
2023
Q2 		$2.83K Hold
22
– – ﹤0.01% 735
2023
Q1 		$2.56K Hold
22
– – ﹤0.01% 776
2022
Q4 		$2.49K Hold
22
– – ﹤0.01% 771
2022
Q3 		$2K Buy
+22
New +$1.86K ﹤0.01% 763

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Matthew Hamilton Rosenberg's DXCM Position: Q4 2024 in Review

Matthew Hamilton Rosenberg sold out of DexCom (DXCM) in Q4 2024, closing a stake of 22 shares — an estimated $1.48K sold.

Matthew Hamilton Rosenberg first reported a position in DXCM in Q3 2022 and held it in 9 quarters. The position peaked at $3.04K in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Matthew Hamilton Rosenberg reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 22 DexCom shares in Q4 2024, an estimated $1.48K.
  • Matthew Hamilton Rosenberg first reported a position in DexCom in Q3 2022 and held it in 9 quarters.
  • Matthew Hamilton Rosenberg's DexCom position peaked at $3.04K in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q4 2024, filed 14 Jan 2025.